Inventor

DUCHATEAU PHILIPPE

FR53 patents

⚠️ This page may combine multiple inventors who share the name “DUCHATEAU PHILIPPE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DUCHATEAU PHILIPPE

CELLECTIS

Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system

Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system

I-CreI meganuclease variants with modified specificity, method of preparation and uses thereof

Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells

Method of engineering multi-input signal sensitive T cell for immunotherapy

Method for in situ inhibition of regulatory T cells

Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system

Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapy

Method for modulating car-induced immune cells activity

Sequential gene editing in primary immune cells

Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients

Modified diatoms for biofuel production

Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system

Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells

Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system

Method to overcome DNA chemical modifications sensitivity of engineered TALE DNA binding domains

Chimeric antigen receptors with integrated controllable functions

Chimeric antigen receptor using antigen recognition domains derived from cartilaginous fish

Targeted gene insertion for improved immune cells therapy

Method for generating t-cells compatible for allogenic transplantation

Targeted gene integration of NK inhibitors genes for improved immune cells therapy

Targeted gene insertion for improved immune cells therapy

Method for generating T-cells compatible for allogenic transplantation

Sequential gene editing in primary immune cells

Tale-protein scaffolds and uses thereof

Engineered immune cells resistant to tumor microenvironment

Method for the generation of compact tale-nucleases and uses thereof

Targeted gene integration of CRS inhibitor genes for improved immune cells therapy

Sequence specific reagents targeting CCR5 in primary hematopoietic cells

Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation

Compact scaffold of Cas9 in the type II CRISPR system

Method of engineering chemotherapy drug resistant T-cells for immunotherapy

Modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins

Method for improving production of car T cells

CELLECTIS SA

Rare-cutting endonucleases for efficient and specific targeting DNA sequences comprising highly repetitive motives

Method to overcome DNA chemical modifications sensitivity of engineered tale DNA binding domains

Universal anti-CD22 chimeric antigen receptor engineered immune cells

Universal chimeric antigen receptor T cells specific for CD22

Repeat variable diresidues for targeting nucleotides

PFIZER

Chimeric antigen receptors targeting B-cell maturation antigen

Chimeric antigen receptors targeting B-cell maturation antigen

Chimeric antigen receptors targeting B-cell maturation antigen

DUCHATEAU PHILIPPE

Method for the generation of compact TALE-nucleases and uses thereof

Method for modulating double-strand break-induced homologous recombination

I-CreI meganuclease variants with modified specificity, method of preparation and uses thereof

ARNOULD SYLVAIN

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

JUILLERAT ALEXANDRE

Transcription activator-like effector (TALE) fusion protein

DELACOTE FABIEN

Method for modulating the efficiency of double-strand break-induced mutagenesis